# Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)

> **NCT03113981** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Societe ACTIVBIOMAT** · enrollment: 340 (actual)

## Conditions studied

- Osteoarthritis, Hip
- Coxarthrosis; Primary
- Coxarthrosis; Secondary
- Osteonecrosis; Aseptic, Idiopathic
- Hip Arthroplasty Replacement
- Hip Arthroplasty, Total
- Hip Arthroplasty

## Interventions

- **DEVICE:** Total Hip Arthroplasty

## Key facts

- **NCT ID:** NCT03113981
- **Lead sponsor:** Societe ACTIVBIOMAT
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-05-08
- **Primary completion:** 2024-12-31
- **Final completion:** 2039-12
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2025-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113981, "Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03113981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*